Crescent Biopharma (CBIO) Enterprise Value (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.27% |
| Dec 31, 2025 | -59.98% |
| Mar 31, 2025 | 35.49% |
| Dec 31, 2024 | -141.43% |
| Sep 30, 2024 | 35.71% |
| Jun 30, 2024 | 28.39% |
| Mar 31, 2024 | 25.15% |
| Dec 31, 2023 | 15.41% |
| Sep 30, 2023 | 14.87% |
| Jun 30, 2023 | 10.72% |
| Mar 31, 2023 | -35.79% |
| Dec 31, 2022 | 7.23% |
| Sep 30, 2022 | 14.29% |
| Jun 30, 2022 | 21.32% |
| Mar 31, 2022 | 15.22% |
| Dec 31, 2021 | 11.45% |
| Sep 30, 2021 | 14.24% |
| Jun 30, 2021 | 10.28% |
| Mar 31, 2021 | 3.33% |
| Dec 31, 2020 | 4.08% |
| Mar 31, 2020 | 2.14% |
| Dec 31, 2019 | 7.42% |
| Sep 30, 2019 | 7.21% |
| Jun 30, 2019 | 5.83% |
| Mar 31, 2019 | 6.84% |
| Dec 31, 2018 | 4.51% |
| Sep 30, 2018 | 4.19% |
| Jun 30, 2018 | 5.44% |
| Mar 31, 2018 | -95.79% |
| Dec 31, 2017 | -9.79% |
| Sep 30, 2017 | 5.27% |
| Jun 30, 2017 | -244.40% |
| Mar 31, 2017 | 13.62% |
| Dec 31, 2016 | 11.55% |
| Sep 30, 2016 | 14.70% |
| Jun 30, 2016 | -36.69% |
| Mar 31, 2016 | 17.04% |
| Dec 31, 2015 | 12.94% |
| Sep 30, 2015 | -33.60% |
| Jun 30, 2015 | 13.60% |
| Mar 31, 2015 | 15.64% |
| Dec 31, 2014 | 10.02% |
| Sep 30, 2014 | 7.33% |
| Jun 30, 2014 | -16.24% |
| Mar 31, 2014 | -2,364.35% |
| Dec 31, 2013 | 69.94% |
| Sep 30, 2013 | 28.65% |
| Jun 30, 2013 | 20.10% |